GH Research Plc (GHRS)
18.07
-0.43
(-2.32%)
USD |
NASDAQ |
Oct 23, 16:00
18.10
+0.03
(+0.17%)
After-Hours: 20:00
GH Research Total Liabilities (Quarterly) : 12.86M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.86M |
| March 31, 2026 | 11.89M |
| December 31, 2025 | 8.527M |
| September 30, 2025 | 10.62M |
| June 30, 2025 | 10.25M |
| March 31, 2025 | 10.24M |
| December 31, 2024 | 9.322M |
| September 30, 2024 | 10.24M |
| June 30, 2024 | 8.299M |
| March 31, 2024 | 7.836M |
| December 31, 2023 | 7.332M |
| Date | Value |
|---|---|
| September 30, 2023 | 6.795M |
| June 30, 2023 | 7.289M |
| March 31, 2023 | 7.429M |
| December 31, 2022 | 4.546M |
| September 30, 2022 | 3.385M |
| June 30, 2022 | 3.095M |
| March 31, 2022 | 4.066M |
| December 31, 2021 | 2.749M |
| September 30, 2021 | 2.033M |
| June 30, 2021 | 4.592M |
| March 31, 2021 | 1.241M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 101.22M |
| Jazz Pharmaceuticals Plc | 6.279B |
| Cosmo NV | -- |
| AstraZeneca PLC | 66.63B |
| GSK Plc | 59.14B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 372.35M |
| Shareholders Equity (Quarterly) | 359.49M |
| Debt to Equity Ratio | 0.001 |
| Current Ratio | 28.70 |
| Net Debt Paydown Yield | 0.00% |